Friday, January 3, 2025 Measuring Innovation: Laboratory Infrastructure to Deliver Essential HIV Clinical Trial Results A box of pipette tips. Credit: NIAID As part of NIAID's participatory process to evaluate its HIV clinical research enterprise and inform future investments, the Institute is sharing priorities for laboratory infrastructure. In the next iteration of the NIAID-supported HIV clinical trials networks, laboratory functions will evolve to align with scientific priorities and research approaches while ensuring the timeliness and the high quality standards that the HIV field relies on for evidence that informs science, licensure and equitable practice. Learn More National Institute of Allergy and Infectious Diseases  |  National Institutes of Health

---

Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. Your subscription may be removed if you do not open our emails for a six-month period. 

This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).

                           

---

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107